Search

Molecular profiling of relapsing craniopharyngioma

Pre-clinical efficacy and biomarker studies of ALK, MAPK and MDM2-p53 inhibitor combinations in neuroblastoma

We want you to have fun when you’re raising funds – but you must ensure you don’t take any risks with safety, and follow the law. It may seem daunting, but if you have any questions, please get in touch.

This issue showcases many examples of how patients and families have empowered themselves to help them face the challenges of cancer.